Anton Jervell
| Name | Anton Jervell |
| Birth name | |
| Birth date | 1901 |
| Birth place | Norway |
| Death date | 1987 |
| Death place | Norway |
| Alma mater | |
| Occupation | Physician, Cardiologist |
| Years active | |
| Organization | |
| Known for | Jervell and Lange-Nielsen syndrome |
| Notable works | |
| Spouse(s) | |
| Website | |
Anton Jervell (1901–1987) was a prominent Norwegian physician and cardiologist, best known for his co-discovery of the Jervell and Lange-Nielsen syndrome, a rare genetic disorder that affects the heart and hearing.
Early Life and Education[edit | edit source]
Anton Jervell was born in Norway in 1901. He pursued his medical education at the University of Oslo, where he developed a keen interest in cardiology. After completing his medical degree, Jervell continued his studies and research in the field of cardiology, focusing on congenital heart conditions.
Career[edit | edit source]
Jervell began his medical career at the Rikshospitalet in Oslo, where he worked alongside other leading cardiologists of his time. His work primarily involved the study of cardiac arrhythmias and congenital heart defects. Jervell's dedication to his field led to significant advancements in the understanding of genetic heart disorders.
Jervell and Lange-Nielsen Syndrome[edit | edit source]
In 1957, Anton Jervell, along with his colleague Fred Lange-Nielsen, published a groundbreaking paper describing a new syndrome characterized by congenital deafness and a prolonged QT interval on the electrocardiogram (ECG). This condition, now known as Jervell and Lange-Nielsen syndrome, is a type of long QT syndrome that is inherited in an autosomal recessive manner. It is associated with mutations in the KCNQ1 and KCNE1 genes, which affect cardiac ion channels.
Legacy[edit | edit source]
Anton Jervell's contributions to cardiology, particularly in the field of genetic heart disorders, have had a lasting impact on medical research and practice. His work laid the foundation for further studies into the genetic basis of cardiac arrhythmias and has helped improve the diagnosis and management of patients with these conditions.
Also see[edit | edit source]
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
|
WikiMD's Wellness Encyclopedia |
| Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD
